Dafaallah Hassabelrasool Osman, MD | |
5900 S Lake Dr, Cudahy, WI 53110-3171 | |
(414) 489-9000 | |
Not Available |
Full Name | Dafaallah Hassabelrasool Osman |
---|---|
Gender | Male |
Speciality | Hospitalist |
Experience | 24 Years |
Location | 5900 S Lake Dr, Cudahy, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1619154432 | NPI | - | NPPES |
100002817 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 50231 (Wisconsin) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Aurora St Lukes Medical Center | Milwaukee, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration approved Xolair (omalizumab) for the treatment of chronic idiopathic urticaria, a form of chronic hives.
Accident Fund Holdings, Inc. recently created a comprehensive narcotics program to help reduce the health risks of these drugs on injured workers and ultimately provide a mechanism for them to get back to work sooner.
Kaiser Health News provides a fresh take on health policy developments with "Appointment Scheduling" by Chris Wildt.
World Health Organization officials on Monday ahead of World TB Day on March 24 said that Asian countries should increase efforts to strengthen health systems to address an increase in cases of drug-resistant tuberculosis, AFP/Google.com reports.
Several recent studies have found that women are more sensitive to pain during periods of low estrogen.
› Verified 4 days ago
Entity Name | Columbia St Marys Hospital Milwaukee Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023064482 PECOS PAC ID: 5890604722 Enrollment ID: O20031105000057 |
News Archive
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration approved Xolair (omalizumab) for the treatment of chronic idiopathic urticaria, a form of chronic hives.
Accident Fund Holdings, Inc. recently created a comprehensive narcotics program to help reduce the health risks of these drugs on injured workers and ultimately provide a mechanism for them to get back to work sooner.
Kaiser Health News provides a fresh take on health policy developments with "Appointment Scheduling" by Chris Wildt.
World Health Organization officials on Monday ahead of World TB Day on March 24 said that Asian countries should increase efforts to strengthen health systems to address an increase in cases of drug-resistant tuberculosis, AFP/Google.com reports.
Several recent studies have found that women are more sensitive to pain during periods of low estrogen.
› Verified 4 days ago
Entity Name | Aurora Medical Group, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration approved Xolair (omalizumab) for the treatment of chronic idiopathic urticaria, a form of chronic hives.
Accident Fund Holdings, Inc. recently created a comprehensive narcotics program to help reduce the health risks of these drugs on injured workers and ultimately provide a mechanism for them to get back to work sooner.
Kaiser Health News provides a fresh take on health policy developments with "Appointment Scheduling" by Chris Wildt.
World Health Organization officials on Monday ahead of World TB Day on March 24 said that Asian countries should increase efforts to strengthen health systems to address an increase in cases of drug-resistant tuberculosis, AFP/Google.com reports.
Several recent studies have found that women are more sensitive to pain during periods of low estrogen.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dafaallah Hassabelrasool Osman, MD Po Box 735044, Chicago, IL 60673-5044 Ph: (800) 326-2250 | Dafaallah Hassabelrasool Osman, MD 5900 S Lake Dr, Cudahy, WI 53110-3171 Ph: (414) 489-9000 |
News Archive
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration approved Xolair (omalizumab) for the treatment of chronic idiopathic urticaria, a form of chronic hives.
Accident Fund Holdings, Inc. recently created a comprehensive narcotics program to help reduce the health risks of these drugs on injured workers and ultimately provide a mechanism for them to get back to work sooner.
Kaiser Health News provides a fresh take on health policy developments with "Appointment Scheduling" by Chris Wildt.
World Health Organization officials on Monday ahead of World TB Day on March 24 said that Asian countries should increase efforts to strengthen health systems to address an increase in cases of drug-resistant tuberculosis, AFP/Google.com reports.
Several recent studies have found that women are more sensitive to pain during periods of low estrogen.
› Verified 4 days ago
Cameron M Malone, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5900 S Lake Dr, Cudahy, WI 53110 Phone: 414-489-9000 | |
Gina Buono, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5900 S Lake Dr, Cudahy, WI 53110 Phone: 414-489-9000 |